Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of RGTA technology on postoperative scars in abdominal skin donor sites
ChiCTR2600127094Phase 4Completed
- Sponsor
- School and Hospital of Stomatology, China Medical University
- Start
- Jun 2026
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of regenerating agents in surgical scar and Surgical wound (2 arms), sponsored by School and Hospital of Stomatology, China Medical University. Primary endpoints: Scar healing condition (Vancouver Scar Scale), Overall healing condition of the scar area and 2 more. Started Jun 2026; status: completed.
02
Drugs
regenerating agents
03
Conditions
surgical scarSurgical wound
Beyond the preview
Go deeper on ChiCTR2600127094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127094.